Empowered Funds’s Atrium Therapeutics RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$163K Buy
+19,729
New +$233K ﹤0.01% 2325

Other funds holding RNA

Empowered Funds's RNA Position: Q3 2026 in Review

Empowered Funds opened a new position in Atrium Therapeutics (RNA) in Q3 2026: 19,729 shares worth $163K. The stake represents ﹤0.01% of the portfolio and ranks #2325 among its holdings.

148 funds tracked by Wall St. Rank hold RNA as of Q3 2026.

  • Empowered Funds held 19,729 shares of Atrium Therapeutics worth $163K as of Q3 2026.
  • Atrium Therapeutics was a new Empowered Funds position in Q3 2026.
  • Atrium Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2325 holding.
  • 148 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.